SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?

To: bpf who wrote (323)4/17/1999 11:27:00 AM
From: JZGalt  Read Replies (1) | Respond to of 399
 
Maybe I can get out of this turkey if they announce a big deal.

Re-read that little quote on John's note. Big pharms control the rate. It is a huge question that ARQL may not be able to wait that long or retain the talent needed going forward.



To: bpf who wrote (323)4/21/1999 10:16:00 PM
From: tommysdad  Read Replies (1) | Respond to of 399
 
Not gonna happen. Pfizer has a big internal combichem effort and just dropped a collaboration with an outfit in England. $100 million over 4 years? Umm, they could buy the whole company for that -- wouldn't make much sense, would it?
And weren't the financials announced today?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News